Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL890676 | 0.90 | F10 (0.74) | F10KLKB1 | |
| SCHEMBL890632 | 0.88 | F10 (0.71) | F10KLKB1 | |
| SCHEMBL6713951 | 0.86 | F10 (0.69) | F10KLKB1 | |
| SCHEMBL799832 | 0.86 | F10 (0.72) | F10KLKB1 | |
| SCHEMBL12045550 | 0.83 | F10 (0.68) | F10KLKB1 | |
| SCHEMBL254113 | 0.83 | F10 (0.72) | F10KLKB1 | |
| SCHEMBL890619 | 0.83 | F10 (0.72) | F10 | |
| SCHEMBL28265311 | 0.83 | RAB9A (0.68) | F10 | |
| SCHEMBL799533 | 0.83 | F10 (0.86) | F10 | |
| Hydrochloric Acid SCHEMBL160886 | 0.83 | F10 (0.71) | F10KLKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170326119-A1 | NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR | MILLENNIUM PHARMACEUTICALS, INC. | 2017-11-16 | — | — | US | disclosed |
| US-9555023-B2 | Pharmaceutical salts and polymorphs of a factor Xa inhibitor | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2017-01-31 | — | — | US | disclosed |
| US-20160101089-A1 | NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR | MILLENNIUM PHARMACEUTICALS, INC. | 2016-04-14 | — | — | US | disclosed |
| US-9221758-B2 | Methods of synthesizing pharmaceutical salts of a factor Xa inhibitor | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2015-12-29 | — | — | US | disclosed |
| US-9061019-B2 | Pharmaceutical salts and polymorphs of a factor Xa inhibitor | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2015-06-23 | — | — | US | disclosed |
| US-20140288028-A1 | NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR | MILLENNIUM PHARMACEUTICALS, INC. | 2014-09-25 | — | — | US | disclosed |
| US-20140046071-A1 | Methods of Synthesizing Pharmaceutical Salts of a Factor Xa Inhibitor | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2014-02-13 | — | — | US | disclosed |
| US-20130064806-A1 | NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR | MILLENNIUM PHARMACEUTICALS, INC. | 2013-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170326119-A1 | NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR | F12, F11, TFPI | F10 10/4885KLKB1 177/4885 |
| US-20140046071-A1 | Methods of Synthesizing Pharmaceutical Salts of a Factor Xa Inhibitor | F12, F11, TFPI | F10 12/4885KLKB1 77/4885 |
| US-20130064806-A1 | NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR | F12, F11, TFPI | F10 10/4885KLKB1 177/4885 |
| US-20140288028-A1 | NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR | F12, F11, TFPI | F10 10/4885KLKB1 177/4885 |
| US-20160101089-A1 | NOVEL PHARMACEUTICAL SALTS AND POLYMORPHS OF A FACTOR XA INHIBITOR | F12, F11, TFPI | F10 10/4885KLKB1 177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.